Section 111 – Nondiscrimination for medical care or government employment — Notice to prospective and current public employees — No effect on private employers.
Effective 3/23/2022 26-61a-111. Nondiscrimination for medical care or government employment — Notice to prospective and current public employees — No effect on private employers. (1) For purposes of medical care, including an organ or tissue transplant, a patient’s use, in accordance with this chapter, of cannabis in a medicinal dosage form or a cannabis product […]
Section 112 – No insurance requirement.
Effective 12/3/2018 26-61a-112. No insurance requirement. Nothing in this chapter requires an insurer, a third-party administrator, or an employer to pay or reimburse for cannabis, a cannabis product, or a medical cannabis device. Enacted by Chapter 1, 2018 Special Session 3
Section 113 – No effect on use of hemp extract — Cannabidiol — Approved drugs.
Effective 5/12/2020 26-61a-113. No effect on use of hemp extract — Cannabidiol — Approved drugs. (1) Nothing in this chapter prohibits an individual from purchasing, selling, possessing, or using a cannabinoid product in accordance with Section 4-41-402. (2) Nothing in this chapter restricts or otherwise affects the prescription, distribution, or dispensing of a product that […]
Section 114 – Severability clause.
Effective 12/3/2018 26-61a-114. Severability clause. (1) If any provision of this title or Laws of Utah 2018, Third Special Session, Chapter 1 or the application of any provision of this title or Laws of Utah 2018, Third Special Session, Chapter 1 to any person or circumstance is held invalid by a final decision of a […]
Section 115 – Analogous to prescribed controlled substances.
Effective 9/23/2019 26-61a-115. Analogous to prescribed controlled substances. When an employee, officer, or agent of the state or a political subdivision makes a finding, determination, or otherwise considers an individual’s possession or use of cannabis, a cannabis product, or a medical cannabis device, the employee, officer, or agent may not consider the individual’s possession or […]
Section 116 – Advertising.
Effective 3/24/2022 26-61a-116. Advertising. (1) Except as provided in this chapter, a person may not advertise regarding the recommendation, sale, dispensing, or transportation of medical cannabis. (2) Notwithstanding any authorization to advertise regarding medical cannabis under this chapter, the person advertising may not advertise: (a) using promotional discounts or incentives; (b) a particular medical cannabis […]
Section 104 – Qualifying condition.
Effective 3/24/2022 26-61a-104. Qualifying condition. (1) By designating a particular condition under Subsection (2) for which the use of medical cannabis to treat symptoms is decriminalized, the Legislature does not conclusively state that: (a) current scientific evidence clearly supports the efficacy of a medical cannabis treatment for the condition; or (b) a medical cannabis treatment […]
Section 105 – Compassionate Use Board.
Effective 3/24/2022 26-61a-105. Compassionate Use Board. (1) (a) The department shall establish a Compassionate Use Board consisting of: (i) seven qualified medical providers that the executive director appoints and the Senate confirms: (A) who are knowledgeable about the medicinal use of cannabis; (B) who are physicians licensed under Title 58, Chapter 67, Utah Medical Practice […]
Section 106 – Qualified medical provider registration — Continuing education — Treatment recommendation — Limited medical provider.
Effective 3/24/2022 26-61a-106. Qualified medical provider registration — Continuing education — Treatment recommendation — Limited medical provider. (1) (a) (i) Except as provided in Subsection (1)(b), an individual may not recommend a medical cannabis treatment unless the department registers the individual as a qualified medical provider in accordance with this section. (ii) Notwithstanding Subsection (1)(a)(i), […]
Section 107 – Standard of care — Physicians and pharmacists not liable — No private right of action.
Effective 3/17/2021 26-61a-107. Standard of care — Physicians and pharmacists not liable — No private right of action. (1) An individual described in Subsection (2) is not subject to the following solely for violating a federal law or regulation that would otherwise prohibit recommending, prescribing, or dispensing medical cannabis, a medical cannabis product, or a […]